Kannel, W.B. , et al.: Risk factors in coronary heart disease—The Framingham-StudyAnn. Int. Med.61: 888-889, 1964.
2.
Kannel, W.B. , et al.: The coronary profile: 12 year follow-up in the Framingham study. J. Occup. Med.9: 611-619, 1967.
3.
Kannel, W.B. , et al.: Type of hypercholesterolemia and risk of coronary heart disease— The Framingham Study-Am. J. Cardio.23: 120,1969.
4.
Leren, P.: The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction—a controlled clinical trial. Acta. Med. Scan. , Supp. 466: 1966.
5.
American Heart Assoc. Comm. on Nutrition.Diet and Heart Disease Statement. Oct. 1968; New York4 pp.
6.
Draper, N.R. and Smith, H.: Applied regression analysis. New York, Wiley, 1968.
7.
Merrell, M. and Schulman, L.E.: Determination of prognosis in chronic disease—Illus— trated by Systemic Lupus Erythematosis—original communication. J. Chronic Dis.1: 12-32, 1954.
8.
Miller, R.G.: Simultaneous statistical inference. New York, McGraw-Hill, 1966.
9.
Dayton, S., et al.: A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Am. H. Assoc. Monograph25: 1969.
10.
Robinson, R.W. and LeBeau, R.J.: Dextro-Thyroxine as a cholesterol-lowering agent in patients with angina pectoris. Circ.28: 531-535, 1963.
11.
Taxay, E.: Clinical evaluation of a thyroid analog in patients with hypercholesterolemia, angina, claudication, and diabetes. A. J. Med. Sci.244(2): 97-102, 1962.
12.
Bechtol, L.D. and Warner, W.L.: Dextrothyroxine for lowering serum cholesterol . Ang.20(10): 565-579, 1969.